An in vitro selected binding protein (affibody) shows conformation- dependent recognition of the respiratory syncytial virus (RSV) G protein

Immunotechnology

Volumn 4, Issue 3-4, 1999, Pages 237-252

  Hansson, Marianne ^a   Ringdahl, Jenny ^a   Robert, Alain ^b   Power, Ultan ^b   Goetsch, Liliane ^b   Ngoc Nguyen, Thien ^b   Uhlén, Mathias ^a   Ståhl, Stefan ^a   Nygren, Per Åke ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Artificial antibody; Combinatorial; Epitope mapping; Library; Phage display; Respiratory syncytial virus

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN CONFORMATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BACTERIOPHAGES; BIOSENSING TECHNIQUES; EPITOPE MAPPING; HN PROTEIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; STAPHYLOCOCCAL PROTEIN A; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0033103888     PISSN: 13802933     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1380-2933(98)00026-8     Document Type: Article

References (50)

1. Clackson T., Wells J.A. In vitro selection from protein and peptide libraries. Trends Biotechnol. 12:1994;173-184.
2. Cortese R., Monaci P., Nicosia A., Luzzago A., Felici F., Galfrè G., Pessi A., Tramontano A., Sollazzo M. Identification of biologically active peptides using random libraries displayed on phage. Curr. Opin. Biotechnol. 6:1995;73-80.
3. Dunn I.S. Phage display of proteins. Curr. Opin. Biotechnol. 7:1996;547-553.
4. Hoogenboom H.R., Bruïne A.P., Hufton S.E., Hoet R.M., Arends J.-W., Roovers R.C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1-20.
5. Nord K., Gunneriusson E., Ringdahl J., Ståhl S., Uhlén M., Nygren P.-Å. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nat. Biotechnol. 15:1997;772-777.
6. Nygren P.-Å., Uhlén M. Scaffolds for engineering novel binding sites in proteins. Curr. Opin. Struct. Biol. 7:1997;463-469.
7. Nilsson B., Moks T., Jansson B., Abrahmsén L., Elmblad A., Holmgren E., Henrichson C., Jones T.A., Uhlén M. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1:1987;107-113.
8. Nord K., Nilsson J., Nilsson B., Uhlén M., Nygren P.-Å. A combinatorial library of an α-helical bacterial receptor domain. Protein Eng. 8:1995;601-608.
9. Hansson M., Ståhl S., Hjorth R., Uhlén M., Moks T. Single-step recovery of a secreted recombinant protein by expanded bed adsorption. Bio/Technology. 12:1994;285-288.
10. Josephson S., Bishop R. Secretion of peptides from E. coli: a production system for the pharmaceutical industry. Trends Biotechnol. 6:1988;218-224.
11. Collins P.L., McIntosh K., Chanock R.M. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;1313-1351 Lippincott-Raven, Philadelphia.
12. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrott R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:1969;422-434.
13. Melero J.A., Garcia-Barreno B., Martinez I., Pringle C.R., Cane P.A. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J. Gen. Virol. 78:1997;2411-2418.
14. Olmsted R.A., Elango N., Prince G.A., Murphy B.R., Johnson P.R., Moss B., Chanock R.M., Collins P.L. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. USA. 83:1986;7462-7466.
15. Murphy B.R., Hall S.L., Kulkarni A.B., Crowe J.E. Jr, Collins P.L., Connors M., Karron R.A., Chanock R.M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:1994;13-36.
16. Neuzil K.M., Johnson J.E., Tang Y.W., Prieels J.P., Slaoui M., Gar N., Graham B.S. Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine. Vaccine. 15:1997;525-532.
17. Oien N.L., Brideau R.J., Walsh E.E., Wathen M.W. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine. 12:1994;731-735.
18. Power U.F., Plotnicky-Gilquin H., Huss T., Robert A., Trudel M., Ståhl S., Uhlén M., Nguyen T.N., Binz H. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology. 230:1997;155-166.
19. Tempest P.R., Bremner P., Lambert M., Taylor G., Furze J.M., Carr F.J., Harris W.J. Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo. Bio/Technology. 9:1991;266-271.
20. Corbeil S., Seguin C., Trudel M. Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2. Vaccine. 14:1996;521-525.
21. Crowe J.E. Jr, Murphy B.R., Chanock R.M., Williamson R.A., Barbas C.F., Burton D.R. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA. 91:1994;1386-1390.
22. Crowe J.E. Jr, Gilmour P.S., Murphy B.R., Chanock R.M., Duan L., Pomerantz R.J., Pilkington G.R. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. J. Infect. Dis. 177:1998;1073-1076.
23. Brandt C., Power U.F., Plotnicky-Gilquin H., Huss T., Nguyen T., Lambert P.H., Binz H., Siegrist C.A. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. J. Infect. Dis. 176:1997;884-891.
24. Murby M., Samuelsson E., Nguyen T.N., Mignard L., Power U., Binz H., Uhlén M., Ståhl S. Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus. Eur. J. Biochem. 230:1995;38-44.
25. Mufson M.A., Örvell C., Rafnar B., Norrby E. Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol. 66:1985;2111-2124.
26. Örvell C., Norrby E., Mufson M.A. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J. Gen. Virol. 68:1987;3125-3135.
27. Martinez I., Dopazo J., Melero J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 78:1997;2419-2429.
28. Corvaïa N., Tournier P., Nguyen T.N., Haeuw J.F., Power U.F., Binz H., Andréoni C. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide. J. Infect. Dis. 176:1997;560-569.
29. Libon C, Corvaïa N, Haeuw JF, Nguyen TN, Stähl S, Bonnefoy J-Y, Andreoni C. The serum albumin-binding region of Streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein. Vaccine 1999;17:406-14.
30. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 20:1981;2361-2370.
31. Rüther U. pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts. Nucleic Acids Res. 10:1982;5765-5772.
32. Murby M., Nguyen T.N., Binz H., Uhlén M., Ståhl S. Pyle D.L. Separations of Biotechnology 3. 1994;336-344 Bookcraft, UK.
33. Cedergren L., Andersson R., Jansson B., Uhlén M., Nilsson B. Mutational analysis of the interaction between staphylococcal protein A and human IgG1. Protein Eng. 6:1993;441-448.
34. Jansson M., Li Y.C., Jendeberg L., Anderson S., Montelione B.T., Nilsson B. High-level production of uniformly 15N- and 13C-enriched fusion proteins in Escherichia coli. J. Biomol. NMR. 7:1996;131-141.
35. Maurer R., Meyer B., Ptashne M. Gene regulation at the right operator (OR) bacteriophage lambda. I. OR3 and autogenous negative control by repressor. J. Mol. Biol. 139:1980;147-161.
36. Nilsson J., Larsson M., Ståhl S., Nygren P.-Å., Uhlén M. Multiple affinity domains for the detection, purification and immobilization of recombinant proteins. J. Mol. Recognit. 9:1996;585-594.
37. Nygren P.-Å., Eliasson M., Abrahmsén L., Uhlén M., Palmcrantz E. Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recognit. 1:1988;69-74.
38. Johnson P.R., Spriggs M.K., Olmsted R.A., Collins P.L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA. 84:1987;5625-5629.
39. Hultman T., Ståhl S., Hornes E., Uhlén M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res. 17:1989;4937-4946.
40. Ståhl S., Sjölander A., Nygren P.-Å., Berzins K., Perlmann P., Uhlén M. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. J. Immunol. Methods. 124:1989;43-52.
41. Gräslund T., Nilsson J., Lindberg A.M., Uhlén M., Nygren P.-Å. Production of a thermostable DNA polymerase by site-specific cleavage of a heat-eluted affinity fusion protein. Protein Expr. Purif. 9:1997;125-132.
42. Nguyen T.N., Uhlén M., Ståhl S. Uhlén M., Hornes E., Olsvik Ø. Advances in Biomagnetic Separation. 1994;73-78 Eaton, Natick, MA.
43. Nguyen T.N., Gourdon M.H., Hansson M., Robert A., Samuelson P., Libon C., Andréoni C., Nygren P.-Å., Binz H., Uhlén M., Ståhl S. Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus. J. Biotechnol. 42:1995;207-219.
44. Köhler G., Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur. J. Immunol. 6:1976;511-519.
45. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
46. Andréoni C., Goetsch L., Libon C., Samuelson P., Nguyen T.N., Robert A., Uhlén M., Binz H., Ståhl S. Flow cytometric quantification of surface-displayed recombinant receptors on staphylococci. Biotechniques. 23:1997;696-704.
47. Nilsson J., Nilsson P., Williams Y., Pettersson L., Uhlén M., Nygren P.-Å. Competitive elution of protein A fusion proteins allows specific recovery under mild conditions. Eur. J. Biochem. 224:1994;103-108.
48. Åkerlind-Stopner B., Utter G., Mufson M.A., Örvell C., Lerner R.A., Norrby E. A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop. J. Virol. 64:1990;5143-5148.
49. Vaughan T.J., Williams A.J., Pritchard K., Osbourn J.K., Pope A.R., Earnshaw J.C., McCafferty J., Hodits R.A., Wilton J., Johnson K.S. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol. 14:1996;309-314.
50. Marasco W.A. Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy. Immunotechnology. 1:1995;1-19.